Earnings Feed
Start Free
Home/Insiders/Klein Peter S
KP
SEC Insider//CIK 0001478007

Klein Peter S

CIK 00014780076 companiesSOUTH SAN FRANCISCO, CA
SEC Profile

Transactions

50

Companies

6

Filings

9

CIK

0001478007

Recent Transactions

50 trades
  • Award
    Denali Therapeutics Inc.$DNLI

    Stock Option (right to buy)

    2026-06-03+19,226→ 19,226 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Common Stock

    2026-06-03+6,408→ 33,941 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Stock Option (right to buy)

    2025-06-03+18,111→ 18,111 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Common Stock

    2025-06-03+6,037→ 27,533 total
  • Disposition to Issuer
    Accolade, Inc.

    Stock Option (Right to Buy)

    2025-04-08−8,600→ 0 total
  • Disposition to Issuer
    Accolade, Inc.

    Stock Option (Right to Buy)

    2025-04-08−20,000→ 0 total
  • Disposition to Issuer
    Accolade, Inc.

    Restricted Stock Units

    2025-04-08−35,021→ 0 total
  • Disposition to Issuer
    Accolade, Inc.

    Common Stock

    2025-04-08$7.03/sh−28,329→ 0 total
  • Award
    F5, INC.$FFIV

    Restricted Stock Unit

    2025-03-13+934→ 934 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Restricted Stock Unit

    2025-03-12−1,309→ 0 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Common Stock

    2025-03-12+1,309→ 13,333 total
  • Gift
    F5, INC.$FFIV

    Common Stock

    2024-09-05−1,000→ 12,024 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2024-08-06−9,196→ 0 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2024-08-06+9,196→ 28,329 total
  • Award
    Accolade, Inc.

    Restricted Stock Units

    2024-08-06+35,021→ 35,021 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Common Stock

    2024-05-31+5,967→ 21,496 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Stock Option (right to buy)

    2024-05-31+17,901→ 17,901 total
  • Award
    F5, INC.$FFIV

    Restricted Stock Unit

    2024-03-14+1,309→ 1,309 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Restricted Stock Unit

    2024-03-13−1,770→ 0 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Common Stock

    2024-03-13+1,770→ 13,024 total
  • Gift
    F5, INC.$FFIV

    Common Stock

    2023-09-05−1,200→ 11,254 total
  • Award
    Accolade, Inc.

    Restricted Stock Units

    2023-08-18+9,196→ 9,196 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2023-07-25−14,060→ 0 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2023-07-25+14,060→ 19,133 total
  • Award
    Palladyne AI Corp.$PDYN

    Common Stock

    2023-06-14+195,059→ 265,066 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Stock Option (right to buy)

    2023-06-01+12,649→ 12,649 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Common Stock

    2023-06-01+4,216→ 15,529 total
  • Award
    F5, INC.$FFIV

    Restricted Stock Unit

    2023-03-09+1,770→ 1,770 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Restricted Stock Unit

    2023-03-08−1,272→ 0 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Common Stock

    2023-03-08+1,272→ 12,454 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2023-02-28−604→ 0 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2023-02-28+604→ 5,073 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2022-11-30+603→ 4,469 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2022-11-30−603→ 604 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2022-08-31−604→ 1,207 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2022-08-31+604→ 3,866 total
  • Award
    Accolade, Inc.

    Restricted Stock Units

    2022-07-26+14,060→ 14,060 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2022-07-21$9.67/sh+2,659→ 3,262 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2022-07-21−2,659→ 0 total
  • Award
    Palladyne AI Corp.$PDYN

    Common Stock

    2022-06-29+57,692→ 70,007 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Common Stock

    2022-06-02+5,986→ 11,313 total
  • Award
    Denali Therapeutics Inc.$DNLI

    Stock Option (right to buy)

    2022-06-02+17,959→ 17,959 total
  • Exercise/Conversion
    Accolade, Inc.

    Restricted Stock Units

    2022-05-31−603→ 1,811 total
  • Exercise/Conversion
    Accolade, Inc.

    Common Stock

    2022-05-31+603→ 603 total
  • Award
    F5, INC.$FFIV

    Restricted Stock Unit

    2022-03-10+1,272→ 1,272 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Restricted Stock Unit

    2022-03-09−1,282→ 0 total
  • Exercise/Conversion
    F5, INC.$FFIV

    Common Stock

    2022-03-09+1,282→ 11,182 total
  • Award
    Accolade, Inc.

    Restricted Stock Units

    2022-03-01+2,414→ 2,414 total
  • Award
    Palladyne AI Corp.$PDYN

    Common Stock

    2021-12-09+12,315→ 12,315 total
  • Award
    Accolade, Inc.

    Restricted Stock Units

    2021-07-22+2,659→ 2,659 total

Companies

6

Recent Filings

9

Address

C/O DENALI THERAPEUTICS INC. 161 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov